Regulatory & Legal

A landmark study reveals 100% tumor control with a personalized radiation therapy, offering profound new hope for patients with inoperable liver cancer.

Sceye's airship completed a 6,400-mile journey, proving its tech for a new era of connectivity and climate monitoring from the stratosphere.

Facing reporting delays, AI-driven energy firm Surya Oil & Gas appoints a new auditor and controller, aiming to bolster investor trust before production restarts.

Auxly Cannabis Group lost its bid for Ayurcann but secured a profitable backup role, showcasing a shrewd strategy in Canada's consolidating cannabis market.

CHC: Creating Healthier Communities adds policy expert Edo Banach to its board, a strategic move to leverage his deep Medicare and Medicaid expertise.

Israel's parliament passes a major R&D tax overhaul, offering huge credits to counter global tax reforms and secure its 'Startup Nation' status.

Inceptio Technology's new ASPICE CL2 certification is more than a badge; it's a strategic key to unlock global partnerships in autonomous trucking.

Ditching the old OEM model for a 'win-win ecosystem,' Chery bets on shared tech and green manufacturing. A global summit will test this bold new vision.

Italian infrastructure giant Mundys can now own nearly 30% of Getlink, a key move in European transport that passed the UK's strict security review.

Satair's new robotic warehouse in Singapore, powered by Swisslog's AutoStore, signals a major shift in aerospace supply chain strategy for the APAC region.

IVY Rx unveils its 2026 compounded GLP-1 program with clear pricing, but operates in a market facing intense FDA warnings and regulatory uncertainty.

With a $2.135M financing round complete, Golden Shield Resources turns its focus to permitting its promising Marudi Mountain gold project in Guyana.

With revenue soaring 265%, Primior Holdings' bet on its GAIA blockchain platform is paying off, bridging real estate with the future of digital assets.

A hidden danger in IV lines causes thousands of preventable deaths. Now, one company is showcasing a new strategy to protect patients from this 'gross gap'.

The diagnostics firm posts strong 2025 growth, but the impending loss of a key partner puts its high-stakes strategic pivot squarely to the test.

IM Cannabis has 180 days to raise its stock price above $1.00 or risk delisting from Nasdaq, highlighting broader struggles in the global cannabis sector.

Sellers returned to the Mid-Atlantic housing market in March, but rising rates and global conflict are creating an uneven and unpredictable spring season.

Gartner's new Adversarial Exposure Validation category signals a major shift in cybersecurity. Find out how AI-driven platforms like Hadrian are leading the way.

A new state-backed tool lets Nevadans compare hospital costs, but providers warn of unintended consequences. Is this the future of healthcare transparency?

Landmark trial shows proton therapy boosts survival and cuts side effects, offering new hope as cancer rates climb in adults under 50.